According to GlobalData, BIOLOX is one of 431 product lines sold in the US hip reconstruction market; these product lines are sold by 35 different manufacturers. The average selling price for BIOLOX decreased in hospitals, health systems, and outside of hospital facilities in 2022. The price of the BIOLOX device can be viewed in GlobalData’s micro pricing report and can be retrieved according to purchase date, facility type, bed size, and geographical region. Buy the report here.
The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches.
In addition, the final selling pricing of medical devices is also impacted by the discounting policy of the manufacturer. Companies such as Renovis Surgical Technologies apply discounts for their devices based on their internal business strategy, inventory control, and monthly or quarterly sales targets. In addition, sale location can also affect the final selling price of a device, both in terms of geographical region and facility type. Prices for the same medical device often vary in hospitals and health systems versus outside of hospital facilities, for example if high volume healthcare institutions can negotiate discounts or rebates based on large purchase sizes.
Renovis Surgical Technologies overview
Renovis Surgical Technologies LLC (Renovis Surgical Technologies) is a medical device company that develops, manufactures and orthopedic implants for trauma, spine, and joint reconstruction surgery. The company offers product such as tapered cementless hip system, acetabular cup system, crosslinked polyethylene acetabular inserts, ceramic femoral heads, cruciate retaining knee, pedicle screw system, interbody system, stand-alone cervical interbody system, stand-alone cage system, cannulated screw system, and external fixator system. It also provides information on spine surgery, knee replacement, and hip replacement. Renovis Surgical Technologies develops tesera trabecular technology to promote bone in-growth and long-term stability. The company operates its offices in California and Texas, the US. Renovis Surgical Technologies is headquartered in Redlands, California, the US.
For a complete picture of BIOLOX, Hip Reconstruction pricing in the US, buy the report here.